Human Xtensions Ltd
Human Xtensions Ltd., a medical robotics company, develops, manufactures, markets, and sells modular medical device for minimally invasive surgical operations in Israel. The company offers HandX, a handheld smart laparoscopy solution for use in laparoscopic surgeries; fenestrated grasper; monopolar hook; monopolar spatula; monopolar scissors; self-righting needle holder; and needle holder. Human … Read more
Human Xtensions Ltd (HUMX) - Net Assets
Latest net assets as of December 2024: ILA2.91 Million ILA
Based on the latest financial reports, Human Xtensions Ltd (HUMX) has net assets worth ILA2.91 Million ILA as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA6.57 Million) and total liabilities (ILA3.66 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA2.91 Million |
| % of Total Assets | 44.34% |
| Annual Growth Rate | -32.25% |
| 5-Year Change | -98.04% |
| 10-Year Change | N/A |
| Growth Volatility | 273.85 |
Human Xtensions Ltd - Net Assets Trend (2019–2024)
This chart illustrates how Human Xtensions Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Human Xtensions Ltd (2019–2024)
The table below shows the annual net assets of Human Xtensions Ltd from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA2.91 Million | -88.84% |
| 2023-12-31 | ILA26.11 Million | -57.74% |
| 2022-12-31 | ILA61.78 Million | -40.90% |
| 2021-12-31 | ILA104.53 Million | -29.76% |
| 2020-12-31 | ILA148.82 Million | +628.49% |
| 2019-12-31 | ILA20.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Human Xtensions Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 18636300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ILA327.67 Million | 11248.37% |
| Total Equity | ILA2.91 Million | 100.00% |
Human Xtensions Ltd Competitors by Market Cap
The table below lists competitors of Human Xtensions Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Baron Capital
PINK:BCAP
|
$21.16K |
|
MILS3F
SA:MILS3F
|
$21.17K |
|
Thal Industries Corporation Ltd
KAR:TICL
|
$21.18K |
|
PREMIER FOODS (FOJ1.SG)
STU:FOJ1
|
$21.20K |
|
YAHOO JAPAN
BE:YOJ
|
$21.16K |
|
Synbio Tech Inc.
TWO:1295
|
$21.14K |
|
KEY TRONIC
BE:KT1
|
$21.12K |
|
ARYZTA N
MU:YZA
|
$21.08K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Human Xtensions Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 26,106,000 to 2,913,000, a change of -23,193,000 (-88.8%).
- Net loss of 22,971,000 reduced equity.
- Other factors decreased equity by 222,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-22.97 Million | -788.57% |
| Other Changes | ILA-222.00K | -7.62% |
| Total Change | ILA- | -88.84% |
Book Value vs Market Value Analysis
This analysis compares Human Xtensions Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 270.96x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 38.50x to 270.96x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | ILA0.77 | ILA29.50 | x |
| 2020-12-31 | ILA5.58 | ILA29.50 | x |
| 2021-12-31 | ILA3.91 | ILA29.50 | x |
| 2022-12-31 | ILA2.31 | ILA29.50 | x |
| 2023-12-31 | ILA0.98 | ILA29.50 | x |
| 2024-12-31 | ILA0.11 | ILA29.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Human Xtensions Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -788.57%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3454.29%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 2.26x
- Recent ROE (-788.57%) is below the historical average (-218.69%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -240.60% | -403.36% | 0.28x | 2.15x | ILA-51.20 Million |
| 2020 | -19.18% | -137.98% | 0.12x | 1.12x | ILA-43.42 Million |
| 2021 | -51.30% | -1921.97% | 0.02x | 1.15x | ILA-64.08 Million |
| 2022 | -72.18% | -1405.36% | 0.04x | 1.17x | ILA-50.77 Million |
| 2023 | -140.33% | -740.10% | 0.14x | 1.34x | ILA-39.25 Million |
| 2024 | -788.57% | -3454.29% | 0.10x | 2.26x | ILA-23.26 Million |
Industry Comparison
This section compares Human Xtensions Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $43,890,333
- Average return on equity (ROE) among peers: 2.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Human Xtensions Ltd (HUMX) | ILA2.91 Million | -240.60% | 1.26x | $21.16K |
| Allmed Solutions Ltd (ALMD) | $45.13 Million | -46.38% | 0.26x | $96.61K |
| Erika Carmel Ltd (BCUR) | $8.97 Million | 138.94% | 4.32x | $46.92K |
| Bio-View Ltd (BIOV) | $23.45 Million | -5.34% | 0.48x | $54.59K |
| Erech Finance Cahalacha Ltd (EFNC) | $-63.00K | 0.00% | 0.00x | $19.28K |
| Endymed (ENDY) | $14.70 Million | 5.78% | 0.34x | $118.10K |
| Epitomee Medical Ltd (EPIT) | $34.80 Million | -16.33% | 0.16x | $567.43K |
| Ilex Medical (ILX) | $109.44 Million | 17.00% | 0.55x | $2.01 Million |
| Pulsenmore Ltd (PULS) | $132.23 Million | -44.29% | 0.36x | $321.83K |
| Sofwave Medical Ltd (SOFW) | $26.34 Million | -31.42% | 0.65x | $3.18 Million |